GWSG
LGND icon

GPS Wealth Strategies Group’s Ligand Pharmaceuticals LGND Stock Holding History

GPS Wealth Strategies Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$13.2K Hold
70
– – 0.01% 360
2025
Q3 		$12.4K Hold
70
– – ﹤0.01% 1040
2025
Q2 		$7.96K Hold
70
– – ﹤0.01% 1081
2025
Q1 		$7.36K Hold
70
– – ﹤0.01% 1073
2024
Q4 		$7.5K Hold
70
– – ﹤0.01% 1011
2024
Q3 		$7.01K Hold
70
– – ﹤0.01% 1027
2024
Q2 		$5.9K Hold
70
– – ﹤0.01% 1032
2024
Q1 		$5.12K Hold
70
– – ﹤0.01% 997
2023
Q4 		$5K Buy
+70
New +$4.13K ﹤0.01% 981

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

GPS Wealth Strategies Group's LGND Position: Q4 2025 in Review

GPS Wealth Strategies Group held its Ligand Pharmaceuticals (LGND) position steady in Q4 2025 at 70 shares worth $13.2K. The position accounts for 0.01% of the portfolio, ranked #360.

GPS Wealth Strategies Group first reported a position in LGND in Q4 2023 and has held it in 9 quarters since. 349 funds tracked by Wall St. Rank hold LGND as of Q4 2025.

  • GPS Wealth Strategies Group held 70 shares of Ligand Pharmaceuticals worth $13.2K as of Q4 2025.
  • GPS Wealth Strategies Group left its Ligand Pharmaceuticals share count unchanged in Q4 2025.
  • Ligand Pharmaceuticals made up 0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #360 holding.
  • GPS Wealth Strategies Group first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • 349 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.